- Clinical diagnosis of atopic dermatitis that has been clinically stable for ≥1 month
- Total body surface area (BSA) of atopic dermatitis involvement ≤35%, excluding
involvement of the face, scalp, and groin
- Presence of two (2) comparable target lesions
- Willing and able to apply study medications as directed, comply with study
instructions, and commit to attending all visits
- Females of childbearing potential must use at least one highly effective method of
birth control. Males with partners of childbearing potential should inform them of
their participation in this clinical study and use highly effective methods of birth
control during the study.
- Concurrent or recent use of certain topical or systemic medications or phototherapy
without a sufficient washout period
- Active or potentially recurrent dermatologic condition other than atopic dermatitis in
the target lesion area that may confound evaluation
- Significant confounding conditions as assessed by study doctor
- History or evidence of allergies requiring acute or chronic treatment (except seasonal
allergic rhinitis)
- Participated in any other trial of an investigational drug or device within 30 days or
participation in a research study concurrent with this study
- Pregnancy or lactation